Early Phase

With your project from day one.

To give your potential drug the best shot at getting into the hands of those who need them, we begin all Phase I and IIa studies with the big picture in mind. Our hospital-based clinical units centralize our approach with on-site labs for the safest and most convenient experience for patients. And with four global locations, we provide in-house access to help you more easily find healthy volunteers and diverse patient populations. This global network means the ability to run Phase I trials from multiple locations at once, with integrated technology to make decisions in real-time.

We are proud to provide the following services:

• Phase I, first-in-human
• Phase IIa, proof-of-concept
• Early product development
• Clinical PK/PD and pharmacometrics
• Ethnobridging/dynabridging studies
• Bioanalytical and biomarkers
• Bioequivalence studies